In times of extreme stress, people fall back on black humor, which explains the joke making the rounds of health care buysiders trying to cope with the relentless selling of biotech and drug stocks.
“Are you hearing anything about a big fund liquidating? This market feels like a big fund is liquidating.”
“Dude, it feels like EVERYONE is liquidating.”
About the Author Reprints
You try to be greedy when others are afraid, and try to be afraid when others are greedy…Warren Buffett
small cap Biotechs have been shorted mercilessly and subsequently subjected to all kinds of hit pieces.
Look no further than JP Morgan’s dishonest and lazy hit job on SGMO today.
Mr. Feuerstein should know a thing or two about shorting a company and then writing misleading hit pieces.
That JPM piece on SGMO was awful. Not only was it factually inaccurate, but the analyst apparently flubbed the numbers horribly. Either sloppy, incredibly stupid, or purposefully malignant, hard to decide which. I have no position in SGMO but my sympathies go out to the shareholders on this one.
Any different than the mob?
MICHAEL
Tom, wait a minute. I’m talking about a cop — that’s mixed up in drugs. I’m talking about ah
– ah – a dishonest cop — a crooked cop who got mixed up in the rackets and got what was
coming to him. That’s a terrific story. And we have newspaper people on the payroll, don’t
we, Tom?
[Hagen nods in the affirmative]
And they might like a story like that.
HAGEN
They might, they just might…
Well, firms are hiring many biotech equity researchers.
Do you think owning MDGL and VKTX is worth at these prices or expecting more downside – if one dares to own these until 2022-23?